Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Novo Holdings

company

About

Novo is a holding company specializing in life science investor with a focus on creating long-term value.

  • 101 - 250

Details

Industries
Finance,Financial Services,FinTech,Venture Capital
Founded date
Jan 1, 1999
Number Of Employee
101 - 250
Operating Status
Active
Investor Type
Venture Capital

Established in 1999, Novo Holdings is the holding company of the Novo Group and manages the Foundation's investment assets.

In addition to being the major shareholder in the Novo Group companies, Novo Holdings invests the wealth of the Foundation in two key categories: 1. Life Science Investments, which includes investing in life science companies at all stages of development; and 2. Financial Investments, which manages a diversified portfolio of equity and fixed income securities.

Working out of Copenhagen, San Francisco and Boston, Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

The purpose of the investments of Novo Holdings is both to grow the assets of the Foundation and to deliver a return that the Foundation can distribute for scientific, social and humanitarian purposes to improve the health and welfare of people.

Investments

Number of Investments
Number of Lead Investments
31
11
Novo Holdings has made 31 investments. Their most recent investment was on Dec 21, 2022, when Doctor Anywhere raised $38.80M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 21, 2022 Doctor Anywhere
Series C $38.80M Health Care Yes
Aug 30, 2022 MedGenome
Series Unknown $50M Biotechnology Yes
Mar 30, 2022 Qure AI
Series C $40M Artificial Intelligence Yes
Jan 25, 2022 Metagenomi
Series B $175M Artificial Intelligence
Aug 24, 2021 Doctor Anywhere
Series C $65.70M Health Care